North America Plasma Fractionation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Immunoglobulin, Albumin, Coagulation Factor Concentrates, Protease Inhibitors, and Other Plasma Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, and Other Applications), and End User (Hospitals and Clinics, Clinical Research Laboratories, and Academic Institutes)

No. of Pages: 113    |    Report Code: TIPRE00026277    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Plasma Fractionation Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Plasma Fractionation Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Plasma Fractionation Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising need for plasma-based treatments
  • 5.1.2 Growing awareness of blood disorders
5.2 Market Opportunities
  • 5.2.1 Expansion in the global healthcare market
  • 5.2.2 Growth in blood plasma-based therapies
5.3 Future Trends
  • 5.3.1 Advances in protein fractionation
  • 5.3.2 Increase in the number of plasma-derived therapies
5.4 Impact of Drivers and Restraints

6. North America Plasma Fractionation Market Regional Analysis

6.1 North America Plasma Fractionation Market Overview
6.2 North America Plasma Fractionation Market Revenue 2019-2028 (US$ Million)
6.3 North America Plasma Fractionation Market Forecast Analysis

7. North America Plasma Fractionation Market Analysis – by Product

7.1 Immunoglobulin
  • 7.1.1 Overview
  • 7.1.2 Immunoglobulin: North America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Albumin
  • 7.2.1 Overview
  • 7.2.2 Albumin: North America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Coagulation Factor Concentrates
  • 7.3.1 Overview
  • 7.3.2 Coagulation Factor Concentrates: North America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Protease Inhibitors
  • 7.4.1 Overview
  • 7.4.2 Protease Inhibitors: North America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Other Plasma Products
  • 7.5.1 Overview
  • 7.5.2 Other Plasma Products: North America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Plasma Fractionation Market Analysis – by Application

8.1 Neurology
  • 8.1.1 Overview
  • 8.1.2 Neurology: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Immunology
  • 8.2.1 Overview
  • 8.2.2 Immunology: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Hematology
  • 8.3.1 Overview
  • 8.3.2 Hematology: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Critical Care
  • 8.4.1 Overview
  • 8.4.2 Critical Care: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Pulmonology
  • 8.5.1 Overview
  • 8.5.2 Pulmonology: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Other Applications
  • 8.6.1 Overview
  • 8.6.2 Other Applications: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Plasma Fractionation Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Other Applications: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinical Research Laboratories
  • 9.2.1 Overview
  • 9.2.2 Other Applications: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic Institutes
  • 9.3.1 Overview
  • 9.3.2 Other Applications: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Plasma Fractionation Market – North America Analysis

10.1 North America
  • 10.1.1 North America Plasma Fractionation Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Plasma Fractionation Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Plasma Fractionation Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Plasma Fractionation Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Plasma Fractionation Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Plasma Fractionation Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Plasma Fractionation Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Plasma Fractionation Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Plasma Fractionation Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Plasma Fractionation Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Plasma Fractionation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Plasma Fractionation Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bharat Serums and Vaccines Limited (BSV)
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bio Products Laboratory Ltd.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 CSL Limited
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Grifols, S.A.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Kedrion S.p.A
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Octapharma AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 SK Plasma
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Bharat Serums and Vaccines Limited (BSV) 
  2. Bio Products Laboratory Ltd.
  3. CSL Limited
  4. Grifols, S.A.
  5. Kedrion S.p.A
  6. Octapharma AG
  7. SK Plasma
north-america-plasma-fractionation-market